HSP inhibitor, SNX-2112, Purity ≥98%

Cat. No.: X24-09-YM072

HSP inhibitor, SNX-2112, Purity ≥98%

Synonym: 908112-43-6; SNX2112; PF 04928473; 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide; HSP inhibitor

  • MDL: MFCD16038907
  • CAS Number: 908112-43-6
  • Compound CID: 24772860
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SNX-2112, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting HSP. The molecular weight of the compound is 464.48, and its molecular formula is C23H27F3N4O3. It targets the HSP90α and HSP90β.
Molecular Weight
464.48
Molecular Formula
C23H27F3N4O3
Targets
HSP90α
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 90 mg/mL (193.76 mM); Water: insoluble; Ethanol: 1 mg/mL (2.15 mM); In vivo: 0.5% CMC + 0.25% Tween 80, 28 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
SNX-2112 can be studied extensively for its potential therapeutic applications in the treatment of various cancers, including breast cancer, prostate cancer, and non-small cell lung cancer.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0